These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14614060)

  • 1. Effects of sub-MIC concentrations of antibiotics on growth of and toxin production by Clostridium difficile.
    Drummond LJ; Smith DGE; Poxton IR
    J Med Microbiol; 2003 Dec; 52(Pt 12):1033-1038. PubMed ID: 14614060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile.
    Gerber M; Walch C; Löffler B; Tischendorf K; Reischl U; Ackermann G
    J Med Microbiol; 2008 Jun; 57(Pt 6):776-783. PubMed ID: 18480337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxin production of Clostridium difficile in sub-MIC of vancomycin and clindamycin alone and in combination with ceftazidime.
    Zarandi ER; Mansouri S; Nakhaee N; Sarafzadeh F; Moradi M
    Microb Pathog; 2017 Jun; 107():249-253. PubMed ID: 28286152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in sensitivity patterns to selected antibiotics in Clostridium difficile in geriatric in-patients over an 18-month period.
    Drummond LJ; McCoubrey J; Smith DGE; Starr JM; Poxton IR
    J Med Microbiol; 2003 Mar; 52(Pt 3):259-263. PubMed ID: 12621092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the Effects of Surotomycin Treatment on Clostridium difficile Toxin A and B Production, Immune Response, and Morphological Changes.
    Endres BT; Bassères E; Khaleduzzaman M; Alam MJ; Chesnel L; Garey KW
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3519-23. PubMed ID: 27021314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of surotomycin on Clostridium difficile viability and toxin production in vitro.
    Bouillaut L; McBride S; Sorg JA; Schmidt DJ; Suarez JM; Tzipori S; Mascio C; Chesnel L; Sonenshein AL
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4199-205. PubMed ID: 25941230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro efficacy of sodium selenite in reducing toxin production, spore outgrowth and antibiotic resistance in hypervirulent Clostridium difficile.
    Pellissery AJ; Vinayamohan PG; Yin HB; Mooyottu S; Venkitanarayanan K
    J Med Microbiol; 2019 Jul; 68(7):1118-1128. PubMed ID: 31172910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fidaxomicin inhibits toxin production in Clostridium difficile.
    Babakhani F; Bouillaut L; Sears P; Sims C; Gomez A; Sonenshein AL
    J Antimicrob Chemother; 2013 Mar; 68(3):515-22. PubMed ID: 23208832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance in large clostridial toxin-negative, binary toxin-positive Clostridium difficile ribotypes.
    Androga GO; Knight DR; Lim SC; Foster NF; Riley TV
    Anaerobe; 2018 Dec; 54():55-60. PubMed ID: 30053486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sub-lethal doses of surotomycin and vancomycin have similar effects on Clostridium difficile virulence factor production in vitro.
    Aldape MJ; Rice SN; Field KP; Bryant AE; Stevens DL
    J Med Microbiol; 2018 Dec; 67(12):1689-1697. PubMed ID: 30307842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of changes in the epidemiology of Clostridium difficile isolated from diarrheal patients in Hungary.
    Terhes G; Urbán E; Sóki J; Szikra L; Konkoly-Thege M; Vollain M; Nagy E
    Anaerobe; 2009 Dec; 15(6):237-40. PubMed ID: 19682411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact on toxin production and cell morphology in Clostridium difficile by ridinilazole (SMT19969), a novel treatment for C. difficile infection.
    Bassères E; Endres BT; Khaleduzzaman M; Miraftabi F; Alam MJ; Vickers RJ; Garey KW
    J Antimicrob Chemother; 2016 May; 71(5):1245-51. PubMed ID: 26895772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic susceptibility of Clostridium difficile isolates from adult patients at two Jamaican hospitals. Clinical and epidemiological implications.
    Heslop OD; King SD; Levett PN; Barton EN; Wynter J
    West Indian Med J; 2001 Mar; 50(1):50-4. PubMed ID: 11398289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile.
    Drudy D; Harnedy N; Fanning S; Hannan M; Kyne L
    Infect Control Hosp Epidemiol; 2007 Aug; 28(8):932-40. PubMed ID: 17620240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fidaxomicin reduces early toxin A and B production and sporulation in Clostridium difficilein vitro.
    Aldape MJ; Packham AE; Heeney DD; Rice SN; Bryant AE; Stevens DL
    J Med Microbiol; 2017 Oct; 66(10):1393-1399. PubMed ID: 28893366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon.
    Berger FK; Rasheed SS; Araj GF; Mahfouz R; Rimmani HH; Karaoui WR; Sharara AI; Dbaibo G; Becker SL; von Müller L; Bischoff M; Matar GM; Gärtner B
    Int J Med Microbiol; 2018 Apr; 308(3):358-363. PubMed ID: 29478838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of 15 antimicrobial agents against clinical isolates of Clostridium difficile in Kuwait.
    Jamal WY; Mokaddas EM; Verghese TL; Rotimi VO
    Int J Antimicrob Agents; 2002 Oct; 20(4):270-4. PubMed ID: 12385683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antibiotics on toxin production and viability of Clostridium perfringens.
    Stevens DL; Maier KA; Mitten JE
    Antimicrob Agents Chemother; 1987 Feb; 31(2):213-8. PubMed ID: 2882731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tigecycline suppresses toxin A and B production and sporulation in Clostridium difficile.
    Aldape MJ; Heeney DD; Bryant AE; Stevens DL
    J Antimicrob Chemother; 2015 Jan; 70(1):153-9. PubMed ID: 25151204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].
    Poilane I; Fantinato C; Cruaud P; Collignon A
    Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.